1117-AA61 201410 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Electronic Prescriptions for Controlled Substances

By this final rule, the Drug Enforcement Administration (DEA) would finalize its regulations to clarify: (1) the criteria by which DEA-registered practitioners may electronically issue controlled substance prescriptions; and (2) the criteria by which DEA-registered pharmacies may receive and archive these electronic prescriptions. The finalized rule would contain modifications from the interim-final rule previously published. The final regulations would modify the requirements that must be met by any registrant who wishes to dispense controlled substances pursuant to electronic prescriptions, including requirements pertaining to authorized software applications. (The final rule would maintain the discretionary usage of electronic prescriptions found in the interim-final rule.)

]]> Economically Significant Previously Published in The Unified Agenda Final Rule Stage Yes No 21 CFR 1300 21 CFR 1304 21 CFR 1306 21 CFR 1311 21 USC 802 21 USC 821 21 USC 827 21 USC 829 21 USC 871(b) No ANPRM 03/05/2001 66 FR 13274 NPRM 06/27/2008 73 FR 36722 NPRM Comment Period End 09/25/2008 Interim Final Rule 03/31/2010 75 FR 16236 Interim Final Rule Comment Period End 06/01/2010 Interim Final Rule Effective 06/01/2010 Final Action 09/00/2015 Docket Number DEA-218 No Businesses None No www.deadiversion.usdoj.gov No No Ruth Carter A. Chief, Policy Evaluation and Analysis Section, Office of Diversion Control 1117 Drug Enforcement Administration DEA 202 598-6812 8701 Morrissette Drive, Springfield VA 22152